These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4895428)

  • 1. Effects of 6-mercaptopurine (NSC-755) in 290 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):655-60. PubMed ID: 4895428
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 5-fluorouracil (NSC-19893) in 389 patients with cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausmans R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):641-53. PubMed ID: 4895427
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):667-73. PubMed ID: 4895430
    [No Abstract]   [Full Text] [Related]  

  • 4. 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.
    Fink DJ; Foye LV
    Cancer Chemother Rep; 1970 Feb; 54(1):31-4. PubMed ID: 4945996
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrosoureas: a reappraisal of clinical trials.
    Katz ME; Glick JH
    Cancer Clin Trials; 1979; 2(4):297-316. PubMed ID: 394866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with mitomycin C in large infrequent doses.
    Godfrey TE; Wilbur DW
    Cancer; 1972 Jun; 29(6):1647-52. PubMed ID: 5064044
    [No Abstract]   [Full Text] [Related]  

  • 7. "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.
    Bertino JR
    Semin Oncol; 1977 Jun; 4(2):203-16. PubMed ID: 301662
    [No Abstract]   [Full Text] [Related]  

  • 8. [218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
    Israel L; Bernard E
    Poumon Coeur; 1968; 24(1):63-8. PubMed ID: 5690023
    [No Abstract]   [Full Text] [Related]  

  • 9. Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
    Slack NM; Jones R
    Cancer Chemother Rep; 1970 Feb; 54(1):53-63. PubMed ID: 4945998
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-mercaptopurine (NSC-755) given intravenously at weekly intervals to patients with advanced cancer.
    Regelson W; Holland JF; Gold GL; Lynch J; Olson KB; Horton J; Hall TC; Krant M; Colsky J; Miller SP; Owens A
    Cancer Chemother Rep; 1967 Sep; 51(5):277-82. PubMed ID: 4863187
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II clinical trials.
    Carter SK; Selawry O
    Natl Cancer Inst Monogr; 1977 Mar; (45):81-92. PubMed ID: 337157
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in the chemotherapy of malignant tumors].
    Cavalli F
    Ther Umsch; 1985 Aug; 42(8):541-6. PubMed ID: 3863258
    [No Abstract]   [Full Text] [Related]  

  • 13. Re-evaluation of methotrexate as an anticancer drug.
    Sullivan RD; Miller E; Zurek WZ; Oberfield RA; Ojima Y
    Surg Gynecol Obstet; 1967 Oct; 125(4):819-24. PubMed ID: 6041727
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.
    Clarysse A; Kenis Y; Mathe G
    Recent Results Cancer Res; 1976; (53):1-552. PubMed ID: 189368
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer chemotherapy.
    Smith LH
    Major Probl Intern Med; 1971; 1():1-197. PubMed ID: 5005758
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical drug development: an analysis of phase II trials, 1970-1985.
    Marsoni S; Hoth D; Simon R; Leyland-Jones B; De Rosa M; Wittes RE
    Cancer Treat Rep; 1987 Jan; 71(1):71-80. PubMed ID: 3791270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC; DeConti RC; Hubbard SP
    Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose 6-mercaptopurine in advanced refractory cancer.
    Esterhay RJ; Aisner J; Levi JA; Wiernik PH
    Cancer Treat Rep; 1978 Aug; 62(8):1229-31. PubMed ID: 688259
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
    Perloff M; Muggia FM; Ackerman C
    Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.